Matthew Cesari
Papers
1
Total Citations
224
H-Index
1
About
Matthew Cesari is a leading gynecologic oncologist whose research has reshaped surgical staging for endometrial cancer. His most influential work centers on refining sentinel lymph node biopsy (SLNB) as a less invasive alternative to full lymphadenectomy in high-grade disease. In his landmark 2020 study, cited over 220 times, Cesari demonstrated that SLNB using indocyanine green achieves high diagnostic accuracy while significantly reducing surgical morbidity compared to traditional lymph node dissection. This contribution has directly influenced clinical guidelines, offering patients with aggressive endometrial tumors a safer, equally effective staging option. Beyond this core achievement, Cesari’s broader research portfolio addresses optimizing surgical techniques and improving outcomes in gynecologic malignancies. His work is widely recognized for bridging the gap between evidence and practice, earning him a reputation as a pragmatic innovator. For students and clinicians, Cesari’s research exemplifies how rigorous comparative effectiveness studies can transform standard-of-care—reducing harm without compromising oncologic safety. His citation record reflects the field’s trust in his data-driven approach to complex surgical decisions.
Research Focus
Key Achievements
Top Papers
- 1